Skip to content

Study · Randomized controlled trial · 2010

3 results

Dose-dependent increase in intratesticular testosterone by very low-dose human chorionic gonadotropin in normal men with experimental gonadotropin deficiency.

Roth MY, Page ST, Lin K, Anawalt BD, Matsumoto AM, Snyder CN, Marck BT, Bremner WJ, Amory JK

The Journal of clinical endocrinology and metabolism19 May 2010Cited by 49 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study3

3 results from studies that gave the peptide. 3 results from people.

  1. 01HumanRandomized controlled trialEfficacy outcome

    In normal men with experimental gonadotropin deficiency, IT-T rose dose-dependently from 77 nmol/liter with 0 IU to 923 nmol/liter with 125 IU hCG.

    In plain wordsIn men with experimental gonadotropin deficiency, testicular testosterone was higher with 125 IU hCG than with 0 IU.

    Outcome
    IncreaseIntratesticular testosterone dose response
    Study

    n: not reported in source

    Comparator
    0 IU hCG
    Outcome group
    Sex hormones and fertility · Reproductive and sexual health
    Studied dose
    125 IU every other day · sc · 10 dAs given in this study (human).

    Measurements

    Intratesticular testosterone concentration
    77 nmol/liter
    0 IU hCG group, after 10 d
    Reported parenthetical interval for intratesticular testosterone concentration
    40 to 122 nmol/liter
    0 IU hCG group, after 10 d
    Intratesticular testosterone concentration
    923 nmol/liter
    125 IU hCG group, after 10 d
    Reported parenthetical interval for intratesticular testosterone concentration
    894 to 1017 nmol/liter
    125 IU hCG group, after 10 d
    p value for dose-dependent intratesticular testosterone increase
    < 0.001 p value
    Very low-dose hCG dose response, reported 0- and 125-IU groups

    Source sentences

    Summary
    IT-T concentrations increased in a dose-dependent manner with very low-dosage hCG administration from 77 nmol/liter (40, 122 nmol/liter) to 923 nmol/liter (894, 1017 nmol/liter) in the 0- and 125-IU groups, respectively (P<0.001).
    1 context sentence
    Summary · context
    We induced experimental gonadotropin deficiency in 37 normal men with the GnRH antagonist acyline and randomized them to receive one of four low doses of hCG: 0, 15, 60, or 125 IU sc every other day or 7.5 g daily testosterone gel for 10 d.
  2. 02HumanRandomized controlled trialMechanism

    In normal men with experimental gonadotropin deficiency, serum hCG correlated significantly with intratesticular testosterone.

    In plain wordsIn men with experimental gonadotropin deficiency, blood hCG levels correlated with testosterone inside the testes.

    Outcome
    Direction not reportedSerum hCG association with IT-T
    Study

    n: not reported in source

    Outcome group
    Sex hormones and fertility · Reproductive and sexual health
    Studied dose
    0, 15, 60, or 125 IU every other day · sc · 10 dAs given in this study (human).

    Measurements

    p value for serum hCG association with intratesticular testosterone
    < 0.01 p value
    Serum hCG versus intratesticular testosterone

    Source sentences

    Summary
    Moreover, serum hCG was significantly correlated with both IT-T and serum testosterone (P<0.01).
    1 context sentence
    Summary · context
    We induced experimental gonadotropin deficiency in 37 normal men with the GnRH antagonist acyline and randomized them to receive one of four low doses of hCG: 0, 15, 60, or 125 IU sc every other day or 7.5 g daily testosterone gel for 10 d.
  3. 03HumanRandomized controlled trialMechanism

    In normal men with experimental gonadotropin deficiency, serum hCG correlated significantly with serum testosterone.

    In plain wordsIn men with experimental gonadotropin deficiency, blood hCG levels correlated with blood testosterone levels.

    Outcome
    Direction not reportedSerum hCG association with serum testosterone
    Study

    n: not reported in source

    Outcome group
    Sex hormones and fertility · Reproductive and sexual health
    Studied dose
    0, 15, 60, or 125 IU every other day · sc · 10 dAs given in this study (human).

    Measurements

    P value for serum hCG correlation with serum testosterone
    < 0.01 P value
    Serum hCG versus serum testosterone

    Source sentences

    Summary
    Moreover, serum hCG was significantly correlated with both IT-T and serum testosterone (P<0.01).
    1 context sentence
    Summary · context
    We induced experimental gonadotropin deficiency in 37 normal men with the GnRH antagonist acyline and randomized them to receive one of four low doses of hCG: 0, 15, 60, or 125 IU sc every other day or 7.5 g daily testosterone gel for 10 d.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Registered trials2

Trials this study reports on, or that list this study as a reference. Registry data from ClinicalTrials.gov.

2 trials · 1 completed · 1 stopped early · 1 with posted results · source ClinicalTrials.gov (opens in a new tab)

WithdrawnPhase 2NCT02147964

ITT-5 Mechanisms of Spermatogenesis in Man

University of Washingtonn = 0est. Jun 2019 to est. Dec 2026

Gonadotropin Deficiency

Trial pageClinicalTrials.govUpdated 18 Dec 2019
CompletedPhase 1/2Results postedNCT00839319

HOP-3 Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone

University of Washingtonn = 59Mar 2009 to Nov 2010

Healthy Males

Trial pageClinicalTrials.govUpdated 11 Jan 2016

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.